Genmab A/S Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 AKRO
|
Akero Therapeutics, Inc. | $28.25 | $1.59 B | -7.1 | 61 | $0 |
 ALEC
|
Alector, Inc. | $4.93 | $420.24 M | -3.14 | 245 | $97.06 M |
 AMLX
|
Amylyx Pharmaceuticals, Inc. | $3.09 | $120.37 M | -1.65 | 384 | $380.79 M |
 APLS
|
Apellis Pharmaceuticals, Inc. | $29.46 | $4.90 B | -11.77 | 702 | $396.59 M |
 ASND
|
Ascendis Pharma A/S | $144.74 | $7.77 B | -14.19 | 879 | $266.72 M |
 BGNE
|
BeiGene, Ltd. | $218.48 | $17.07 B | -20.76 | 10000 | $2.46 B |
 BPMC
|
Blueprint Medicines Corporation | $92.44 | $6.47 B | -21.48 | 638 | $249.38 M |
 CYTK
|
Cytokinetics, Incorporated | $52.35 | $6.05 B | -9.78 | 423 | $7.53 M |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $14.16 | $1.12 B | -5.11 | 169 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $26.07 | $1.65 B | -11.47 | 97 | $0 |
 LEGN
|
Legend Biotech Corporation | $49.27 | $8.31 B | -17.66 | 2200 | $285.14 M |
 MRTX
|
Mirati Therapeutics, Inc. | $58.70 | $4.12 B | -4.82 | 587 | $12.44 M |
 PCVX
|
Vaxcyte, Inc. | $113.14 | $7.72 B | -16.54 | 254 | $0 |
 TERN
|
Terns Pharmaceuticals, Inc. | $8.52 | $462.44 M | -5.67 | 66 | $0 |
 TVTX
|
Travere Therapeutics, Inc. | $14.01 | $542.80 M | -1.32 | 380 | $145.24 M |